Welcome!

News Feed Item

Final Day of the 2014 BIO International Convention to Feature the Annual Scientific American WorldView Scorecard, BIO Idea Hackathon and Look at FDA’s Critical Path Initiative

The 2014 BIO International Convention, the world’s largest biotechnology event, enters its fourth and final day today at the San Diego Convention Center. Hosted by the Biotechnology Industry Organization, this year’s event is expected to attract more than 3,000 biotechnology companies and more than 15,000 attendees from 48 states and 65 countries.

Upcoming Convention Highlights Include:

  • Super Session: Scientific American WorldView Super Session - Biotech: We are the World, Thursday, June 26
    What is happening in biotechnology and life science development on the global stage? What are the most pressing issues of our time that have every nation looking to science as a solution? As the world continues to flatten, individual countries are finding new ways to grow their innovation engines, and in some cases, are hoping to outshine the US. Come to the annual Scientific American WorldView super session to hear a dynamic panel of international industry luminaries examine the future of global innovation in a lively candid conversation. Moderated by television and radio journalist, David Brancaccio, host of Marketplace Morning Report, this session will explore key themes from Scientific American’s annual biotechnology edition, featuring the WorldView Scorecard and fresh perspectives on international life science development.
  • Super Session: The Next Big Deal: The Global Dealmaker Perspective, Thursday, June 26
    2013 delivered in a big way for each of the major deal-making outlets with nearly three times the number of IPOs as in 2012. The M&A market opened up with the total dollars spent on acquisitions reaching the highest in five years. Strong deal terms with large upfront payments for early stage assets were also seen in 2013 as exemplified with Moderna’s $240M upfront from Astrazeneca and Oncomed’s $177M upfront from Celgene. Will these upward trends continue? How will these changing dynamics impact dealmaking in the coming year? What do dealmakers expect will be the result in 2014? Campbell Alliance and BIO are pleased to present updated findings from two unique forward-looking measures of dealmaking in the industry – the Campbell Alliance Dealmakers’ Intentions Study and the BIO One-on-One Partnering Forecast. Based on a survey of more than 150 industry executives, business development professionals, and financial institutions, Dealmakers’ Intentions provides insight into what will likely drive the industry’s partnering and M&A efforts moving forward, and the implications for deal-making over the next year or more. Now in its sixth year, new analysis in 2014 will include year-over-year trends, additional deal metrics, and broader M&A data. Incorporating a global perspective, a highly distinguished panel of dealmakers will then explore the impact these market forces will have on pharmaceutical and biotech companies as they position themselves to make that next big deal.
  • BIO Idea Hack hosted by MIT [email protected] Medicine, Thursday, June 26
    With advances in technology, transformative government incentives, and increasing partnerships, now is the best time in history to be a healthcare entrepreneur. Those with a fresh take on healthcare's pain points, including industry professionals along with patients, engineers, designers and entrepreneurs, have the ability to make a sizable and rapid impact. This gathering of diverse perspectives will bring industry stakeholders, clinicians, entrepreneurs, and engineers together to tackle complex health challenges with the aim to innovate testable, fundable solutions.
  • New Technologies to Save Us In a Disaster: Opportunities in the Public-Private Partnership to Develop Medical Countermeasures, Thursday, June 26
    In the decade since the US Congress adopted Project Bioshield, more than $5 billion has been invested in the biodefense sector. This session will explore recent trends and new developments in the advanced development of medical countermeasures (MCMs). The session will provide an update on the status of the Centers of Innovation for Advanced Development and Manufacture and opportunities for drug developers. It will also provide perspectives on the need for novel technologies and key considerations for companies entering the biodefense sector as it matures.
  • The Salford Lung Study: An Innovative 'Real World' Study Design for Chronic Conditions, Thursday, June 26
    The 12-month Salford (UK) Lung Study uses an integrated electronic patient record to assess the safety and effectiveness of Relovair, GlaxoSmithKline's late-phase follow-up to Advair, in chronic obstructive pulmonary disease and asthma. Results are intended to help healthcare decision- makers better assess the drug's potential at an earlier stage. The panel will address the complexities of “real-world” studies and how healthcare providers and regulators can use the data generated to understand the benefits of such studies, particularly for chronic conditions managed in community settings.
  • FDA's Critical Path Initiative: Progress in the First Decade and Promise for the Next, Thursday, June 26
    In 2004, the FDA launched the Critical Path Initiative (CPI), which was a response to the needs and challenges faced by medical product developers. Recognizing that no one organization possesses the resources and expertise to solve medical product development problems, the CPI called for a consortium or public-private-partnership approach to modernize the process whereby FDA-regulated products are developed and evaluated. A brief videotaped overview of the CPI will be provided by its chief architect, Dr. Janet Woodcock (CDER/FDA). Then speakers from the FDA, and industry and non-profit organizations will reflect on certain aspects of CPI that have been accomplished through consortia, present the challenges faced by organizations working in the "pre-competitive" space, and explore options for optimizing future collaborations.
  • Biotech Battle of the Wits 2014, Thursday, June 26
    Back for its third year, well-known biotech journalist Chris Morrison will emcee this rapid-fire, interactive debate on the industry’s hot-button issues featuring three biotech trendsetters. Listen as panelists provide their off-the-cuff opinions on the industry’s most controversial and topical issues. What is the strangest biotech idea you’ve come across? How can a company bounce back from a Phase III failure? To drive the debate, audience members can ask questions live or via Twitter (@BioBanter) and vote for presenters online via Twitter or text. The winner of this session will receive 120 uninterrupted seconds to sound off on the topic of their choice.
  • BIO Career Fair, Thursday, June 26
    The 2014 BIO Career Fair is free to all job seekers. Co-located with the 2014 BIO International Convention, the BIO Career Fair will give attendees access to many of the world’s leading life science companies.

Day Three Session Highlights Included:

Follow the 2014 Convention @BIOConvention, and join the conversation @IAmBIOtech.

The Convention program features more than 160 sessions in 8 breakout sessions and 9 specialty forums. The majority of attendees, 70 percent, are c-level executives. They split evenly from large companies of 500 or more employees and small companies of 50 employees or less.

The BIO International Convention is the largest global event for the biotechnology industry and attracts the biggest names in biotech, offers key networking and partnering opportunities, and provides insights and inspiration on major trends affecting the industry. The Convention will highlight the latest trends and the newest opportunities for executives, investors, scientists, policy leaders, and media from around the world. Speakers at the sessions will share breakthroughs in medicine, diagnostics, the environment, energy production, business operations, financing, partnerships, policy issues and food and agriculture. Visit http://convention.bio.org/program/ for the most up-to-date program and speaker information.

The Convention also features the BIO Business Forum, which has grown over the past thirteen years to become the industry's largest partnering event. This year’s Convention is set to break all previous partnering records, with over 28,000 meetings expected to take place. Powered by BIO's One-on-One Partnering™ System, the BIO Business Forum™ fosters the opportunity for companies to initiate business contacts in a friendly environment and schedule private meetings prior to the Convention.

Upcoming BIO Events

BIO Latin America Conference
September 9-11, 2014
Rio de Janeiro, Brazil

Livestock Biotech Summit
September 16-18, 2014
Sioux Falls, SD

About BIO

BIO is the world's largest trade association representing biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world’s largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world. BIOtechNOW is BIO's blog chronicling “innovations transforming our world” and the BIO Newsletter is the organization’s bi-weekly email newsletter. Subscribe to the BIO Newsletter.

For more information:
Visit http://www.bio.org
Follow us on Twitter @IAmBiotech
Join us on LinkedIn/MyBio
Become a fan at facebook.com/IAmBiotech

More Stories By Business Wire

Copyright © 2009 Business Wire. All rights reserved. Republication or redistribution of Business Wire content is expressly prohibited without the prior written consent of Business Wire. Business Wire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
"We're a cybersecurity firm that specializes in engineering security solutions both at the software and hardware level. Security cannot be an after-the-fact afterthought, which is what it's become," stated Richard Blech, Chief Executive Officer at Secure Channels, in this SYS-CON.tv interview at @ThingsExpo, held November 1-3, 2016, at the Santa Clara Convention Center in Santa Clara, CA.
Most companies are adopting or evaluating container technology - Docker in particular - to speed up application deployment, drive down cost, ease management and make application delivery more flexible overall. As with most new architectures, this dream takes a lot of work to become a reality. Even when you do get your application componentized enough and packaged properly, there are still challenges for DevOps teams to making the shift to continuous delivery and achieving that reduction in cost ...
Enterprise architects are increasingly adopting multi-cloud strategies as they seek to utilize existing data center assets, leverage the advantages of cloud computing and avoid cloud vendor lock-in. This requires a globally aware traffic management strategy that can monitor infrastructure health across data centers and end-user experience globally, while responding to control changes and system specification at the speed of today’s DevOps teams. In his session at 20th Cloud Expo, Josh Gray, Chie...
To get the most out of their data, successful companies are not focusing on queries and data lakes, they are actively integrating analytics into their operations with a data-first application development approach. Real-time adjustments to improve revenues, reduce costs, or mitigate risk rely on applications that minimize latency on a variety of data sources. Jack Norris reviews best practices to show how companies develop, deploy, and dynamically update these applications and how this data-first...
Intelligent Automation is now one of the key business imperatives for CIOs and CISOs impacting all areas of business today. In his session at 21st Cloud Expo, Brian Boeggeman, VP Alliances & Partnerships at Ayehu, will talk about how business value is created and delivered through intelligent automation to today’s enterprises. The open ecosystem platform approach toward Intelligent Automation that Ayehu delivers to the market is core to enabling the creation of the self-driving enterprise.
"At the keynote this morning we spoke about the value proposition of Nutanix, of having a DevOps culture and a mindset, and the business outcomes of achieving agility and scale, which everybody here is trying to accomplish," noted Mark Lavi, DevOps Solution Architect at Nutanix, in this SYS-CON.tv interview at @DevOpsSummit at 20th Cloud Expo, held June 6-8, 2017, at the Javits Center in New York City, NY.
"We're here to tell the world about our cloud-scale infrastructure that we have at Juniper combined with the world-class security that we put into the cloud," explained Lisa Guess, VP of Systems Engineering at Juniper Networks, in this SYS-CON.tv interview at 20th Cloud Expo, held June 6-8, 2017, at the Javits Center in New York City, NY.
As more and more companies are making the shift from on-premises to public cloud, the standard approach to DevOps is evolving. From encryption, compliance and regulations like GDPR, security in the cloud has become a hot topic. Many DevOps-focused companies have hired dedicated staff to fulfill these requirements, often creating further siloes, complexity and cost. This session aims to highlight existing DevOps cultural approaches, tooling and how security can be wrapped in every facet of the bu...
Historically, some banking activities such as trading have been relying heavily on analytics and cutting edge algorithmic tools. The coming of age of powerful data analytics solutions combined with the development of intelligent algorithms have created new opportunities for financial institutions. In his session at 20th Cloud Expo, Sebastien Meunier, Head of Digital for North America at Chappuis Halder & Co., discussed how these tools can be leveraged to develop a lasting competitive advantage ...
Docker containers have brought great opportunities to shorten the deployment process through continuous integration and the delivery of applications and microservices. This applies equally to enterprise data centers as well as the cloud. In his session at 20th Cloud Expo, Jari Kolehmainen, founder and CTO of Kontena, discussed solutions and benefits of a deeply integrated deployment pipeline using technologies such as container management platforms, Docker containers, and the drone.io Cl tool. H...
In his session at @ThingsExpo, Dr. Robert Cohen, an economist and senior fellow at the Economic Strategy Institute, presented the findings of a series of six detailed case studies of how large corporations are implementing IoT. The session explored how IoT has improved their economic performance, had major impacts on business models and resulted in impressive ROIs. The companies covered span manufacturing and services firms. He also explored servicification, how manufacturing firms shift from se...
Connecting to major cloud service providers is becoming central to doing business. But your cloud provider’s performance is only as good as your connectivity solution. Massive Networks will place you in the driver's seat by exposing how you can extend your LAN from any location to include any cloud platform through an advanced high-performance connection that is secure and dedicated to your business-critical data. In his session at 21st Cloud Expo, Paul Mako, CEO & CIO of Massive Networks, wil...
You know you need the cloud, but you’re hesitant to simply dump everything at Amazon since you know that not all workloads are suitable for cloud. You know that you want the kind of ease of use and scalability that you get with public cloud, but your applications are architected in a way that makes the public cloud a non-starter. You’re looking at private cloud solutions based on hyperconverged infrastructure, but you’re concerned with the limits inherent in those technologies.
The question before companies today is not whether to become intelligent, it’s a question of how and how fast. The key is to adopt and deploy an intelligent application strategy while simultaneously preparing to scale that intelligence. In her session at 21st Cloud Expo, Sangeeta Chakraborty, Chief Customer Officer at Ayasdi, will provide a tactical framework to become a truly intelligent enterprise, including how to identify the right applications for AI, how to build a Center of Excellence to ...
SYS-CON Events announced today that Massive Networks will exhibit at SYS-CON's 21st International Cloud Expo®, which will take place on Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. Massive Networks mission is simple. To help your business operate seamlessly with fast, reliable, and secure internet and network solutions. Improve your customer's experience with outstanding connections to your cloud.